GRACE MONGER: Open Payments
NPI 1497425888 · JEFFERSON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 39 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $112 |
| Madrigal Pharmaceuticals | 5 | $104 |
| Ardelyx, Inc. | 4 | $99 |
| Celltrion USA Inc. | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 8 | $74 |
| Lilly USA, LLC | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
Products named: REZDIFFRA, IBSRELA, RINVOQ, ENTYVIO, VEGZELMA, VOQUEZNA, OMVOH, DUPIXENT.
Industry payments across LA — which companies pay providers there.
